FY2027 EPS Estimates for Cardinal Health Boosted by Analyst

Key Points

• Analysts at Zacks Research have raised their FY2027 earnings per share (EPS) estimates for Cardinal Health to $9.79, slightly above the previous estimate of $9.78, while the consensus for the current full year stands at $7.95 per share.
• Wells Fargo upgraded Cardinal Health from an "equal weight" to an "overweight" rating, increasing its target price from $136.00 to $179.00, reflecting positive sentiment among various analysts regarding the stock.
• The company's recent quarterly dividend was increased to $0.5107 per share, representing an annualized yield of 1.29%, indicating a commitment to returning value to shareholders.

Cardinal Health, Inc. (NYSE:CAH - Free Report) - Stock analysts at Zacks Research raised their FY2027 EPS estimates for Cardinal Health in a research report issued on Tuesday, July 22nd. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $9.79 for the year, up from their previous estimate of $9.78. The consensus estimate for Cardinal Health's current full-year earnings is $7.95 per share.

A number of other research analysts have also recently weighed in on the stock. Wells Fargo & Company upgraded shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $136.00 to $179.00 in a research note on Tuesday, June 3rd. Robert W. Baird lifted their target price on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Citigroup restated a "neutral" rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Finally, Morgan Stanley raised their price objective on Cardinal Health from $181.00 to $190.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 16th. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $158.07.

Cardinal Health Stock Up 0.3%

Shares of CAH stock opened at $158.17 on Friday. Cardinal Health has a 52 week low of $96.05 and a 52 week high of $168.44. The company has a market cap of $37.75 billion, a price-to-earnings ratio of 24.67, a price-to-earnings-growth ratio of 1.56 and a beta of 0.68. The firm has a 50 day moving average of $159.37 and a 200-day moving average of $141.27.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. The company had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. Cardinal Health's revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.08 EPS.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st were given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.29%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date was Tuesday, July 1st. Cardinal Health's dividend payout ratio is 31.83%.

Institutional Trading of Cardinal Health

Several institutional investors and hedge funds have recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. acquired a new position in shares of Cardinal Health during the 1st quarter worth about $26,000. Tompkins Financial Corp boosted its stake in Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after acquiring an additional 128 shares during the last quarter. Bellwether Advisors LLC acquired a new position in Cardinal Health during the fourth quarter valued at approximately $32,000. GW&K Investment Management LLC lifted its holdings in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after purchasing an additional 144 shares in the last quarter. Finally, Itau Unibanco Holding S.A. acquired a new position in Cardinal Health in the 4th quarter worth $36,000. Institutional investors and hedge funds own 87.17% of the company's stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.